New migraine pill tested for fast relief
NCT ID NCT05903040
Summary
This study tested how well and how safely a medication called lasmiditan works to stop migraine attacks. Researchers enrolled 100 people with migraines to take the drug when a migraine started and tracked their pain and side effects. The goal was to see how effective this treatment is in everyday, real-world use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
IRCCS National Neurological Institute "C. Mondino" Foundation
Pavia, 27100, Italy
-
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
Florence, 50134, Italy
Conditions
Explore the condition pages connected to this study.